Although studies focusing on IAPP, insulin, and IGF are stimulating and may lead to exciting developments, one must be careful to draw definitive conclusions regarding multi-factorial diseases such as AD, even if it has been analyzed through the prism of the glucose metabolism. This evidence concerns the gene IGF1 and Alzheimer disease.